913722-65-3

Upstream product

• 913722-73-3 6-nitro-4-phenyl-1H-benzo[d]imidazole 
• 100-39-0 benzyl bromide 
• 98-80-6 phenylboronic acid 
• 206759-50-4 4-bromo-6-nitro-1H-benzo[d]imidazole 

Downstream Products

• 913722-68-6 3-benzyl-N-methyl-N-(2-(methylthio)pyrimidin-4-yl)-7-phenyl-3H-benzo[d]imidazol-5-amine 
• 913722-70-0 N-Methyl-N-(2-(methylsulfinyl)pyrimidin-4-yl)-7-phenyl-3H-benzo[d]imidazol-5-amine 
• 913722-69-7 N-methyl-N-(2-(methylthio)pyrimidin-4-yl)-7-phenyl-3H-benzo[d]imidazol-5-amine 
• 913722-67-5 3-benzyl-N-methyl-7-phenyl-3H-benzo[d]imidazol-5-amine 
• 913722-66-4 3-benzyl-7-phenyl-3H-benzo[d]imidazol-5-amine 

Relevant academic research and scientific papers

BENZIMIDAZOLE COMPOUNDS AS HDAC6 INHIBITORS

Novel compounds of Formula I are described, where the compounds are selective HDAC6 inhibitors suitable for treatment of diseases associated with HDAC6, where X, Y, Z, A1, A2, Q1 and Q2 are as described.

SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present invention relates to compounds having the general structure: (I) and pharmaceutically acceptable salts and hydrates thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple m

Substituted heterocyclic compounds and methods of use

The present invention relates to compounds having the general structure: and pharmaceutically acceptable salts and hydrates thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myelo